Predict your next investment

Corporation
MOBILE & TELECOMMUNICATIONS | RFID Systems
zestlabs.com

See what CB Insights has to offer

Executives

13

Board of Directors

1

Zest Labs Board of Director

1 Board of directors

Zest Labs has 1 board of directors, including Ketan Patel.

Name

Firm

Work History

Other Seats

Ketan Patel

Ketan Patel is a Partner with F-Prime Capital and has worked in the healthcare sector as an investor, consultant, and physician. Prior to joining F-Prime Capital in 2007, Dr. Patel advised biopharmaceutical and medical device companies on brand strategy, clinical development plans, and business development activities in the corporate consulting division of Leerink Swann & Company. Dr. Patel served as a physician at the VA Boston Healthcare System and at Weill Cornell Medical Center-New York Presbyterian Hospital and Memorial-Sloan Kettering Cancer Center where he completed his internal medicine training. Dr. Patel focuses on investing in therapeutics and medical device companies and has served as a director or board observer of Aclaris Therapeutics, Acorn Cardiovascular, Amphora Medical, Bioconnect Systems, Eywa Pharma, Ivenix, Laurus Labs, Medwell Ventures, Menlo Therapeutics, NextWave Pharmaceuticals, Vicept Therapeutics, and Xcyton Diagnostics. Dr. Patel is a graduate of Tufts University School of Medicine, where he received both his MD and MBA as part of that institution's Healthcare Management Program and was elected to the Alpha Omega Alpha Medical Honor Society. He completed his undergraduate studies in biology and economics with highest honors at Rutgers University. Dr. Patel focuses on investing in therapeutics and medical device companies and has served as a director or board observer of Aclaris Therapeutics, Acorn Cardiovascular, Amphora Medical, Bioconnect Systems, Eywa Pharma, Avalyn Pharma, Ivenix, Laurus Labs, Medwell Ventures, Menlo Therapeutics, NextWave Pharmaceuticals, NFlection Therapeutics, Vicept Therapeutics, and Xcyton Diagnostics. Dr. Patel is a graduate of Tufts University School of Medicine, where he received both his MD and MBA as part of that institution’s Healthcare Management Program and was elected to the Alpha Omega Alpha Medical Honor Society. He completed his undergraduate studies in biology and economics with highest honors at Rutgers University.

Zest Labs

Name

Ketan Patel

Firm

Work History

Ketan Patel is a Partner with F-Prime Capital and has worked in the healthcare sector as an investor, consultant, and physician. Prior to joining F-Prime Capital in 2007, Dr. Patel advised biopharmaceutical and medical device companies on brand strategy, clinical development plans, and business development activities in the corporate consulting division of Leerink Swann & Company. Dr. Patel served as a physician at the VA Boston Healthcare System and at Weill Cornell Medical Center-New York Presbyterian Hospital and Memorial-Sloan Kettering Cancer Center where he completed his internal medicine training. Dr. Patel focuses on investing in therapeutics and medical device companies and has served as a director or board observer of Aclaris Therapeutics, Acorn Cardiovascular, Amphora Medical, Bioconnect Systems, Eywa Pharma, Ivenix, Laurus Labs, Medwell Ventures, Menlo Therapeutics, NextWave Pharmaceuticals, Vicept Therapeutics, and Xcyton Diagnostics. Dr. Patel is a graduate of Tufts University School of Medicine, where he received both his MD and MBA as part of that institution's Healthcare Management Program and was elected to the Alpha Omega Alpha Medical Honor Society. He completed his undergraduate studies in biology and economics with highest honors at Rutgers University. Dr. Patel focuses on investing in therapeutics and medical device companies and has served as a director or board observer of Aclaris Therapeutics, Acorn Cardiovascular, Amphora Medical, Bioconnect Systems, Eywa Pharma, Avalyn Pharma, Ivenix, Laurus Labs, Medwell Ventures, Menlo Therapeutics, NextWave Pharmaceuticals, NFlection Therapeutics, Vicept Therapeutics, and Xcyton Diagnostics. Dr. Patel is a graduate of Tufts University School of Medicine, where he received both his MD and MBA as part of that institution’s Healthcare Management Program and was elected to the Alpha Omega Alpha Medical Honor Society. He completed his undergraduate studies in biology and economics with highest honors at Rutgers University.

Other Seats

Zest Labs

Zest Labs Management Team

13 Team Members

Zest Labs has 13 executives. Zest Labs's founder is Ashish Asthana. Zest Labs's current Chief Executive Officer, President is Peter Mehring.

Name

Work History

Title

Status

Peter Mehring

Chief Executive Officer, President

Current

Scott Durgin

Chief Technology Officer

Current

Ashish Asthana

Founder

Former

Naresh Batra

President, Chief Operating Officer

Former

David Bostwick

Chief Financial Officer

Former

Name

Peter Mehring

Scott Durgin

Ashish Asthana

Naresh Batra

David Bostwick

Work History

Title

Chief Executive Officer, President

Chief Technology Officer

Founder

President, Chief Operating Officer

Chief Financial Officer

Status

Current

Current

Former

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.